Healix

Successful Establishment of an Antimicrobial Stewardship Program (ASP) for Outpatient Parenteral Antimicrobial Therapy (OPAT)

Authors:
Ramesh V. Nathan, MD – Mazur, Statner, Dutta, Nathan, PC, Thousand Oaks, CA
John S. Adams, MD – Knoxville Infectious Disease Consultants, PC, Knoxville, TN
Robin H. Dretler, MD – Infectious Disease Specialists of Atlanta, PC, Decatur, GA
Quyen Luu, MD – Central Georgia Infectious Diseases, Macon, GA
Brian S. Metzger, MD – Austin Infectious Disease Consultants, Austin, TX
Claudia P. Schroeder, PharmD, PhD – Healix Infusion Therapy, Inc., Sugar Land, TX
Kimberly Couch, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX
Lucinda J. Van Anglen, PharmD – Healix Infusion Therapy, Inc., Sugar Land, TX

View Poster View Abstract

View All

Phase II and Phase III Studies

Healix regularly and actively supports Phase II and Phase III clinical trials in each of our specialty areas, including active studies in Multiple Sclerosis and Intestinal Bowel Disease.

For information on partnering with Healix on a study, please contact us.

FacebookTwitterLinkedInarrow1arcsearchiconowdtnotfound